PE20211243A1 - Procedimiento y productos intermedios para la preparacion de bilastina - Google Patents

Procedimiento y productos intermedios para la preparacion de bilastina

Info

Publication number
PE20211243A1
PE20211243A1 PE2021000095A PE2021000095A PE20211243A1 PE 20211243 A1 PE20211243 A1 PE 20211243A1 PE 2021000095 A PE2021000095 A PE 2021000095A PE 2021000095 A PE2021000095 A PE 2021000095A PE 20211243 A1 PE20211243 A1 PE 20211243A1
Authority
PE
Peru
Prior art keywords
preparation
bilastin
procedure
intermediate products
solvate
Prior art date
Application number
PE2021000095A
Other languages
English (en)
Inventor
Herrero Gonzalo Hernandez
Dominguez Neftali Garcia
Poladura Pablo Moran
Garcia Tania Gonzalez
Gonzalez Alvaro Ganza
Cerdeiras Paloma Tato
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of PE20211243A1 publication Critical patent/PE20211243A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/39—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester
    • C07C67/42—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester by oxidation of secondary alcohols or ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Referido a un procedimiento para preparar un compuesto de formula (III) o un solvato del mismo, en la que X es un grupo saliente; y R1 es alquilo C1-C6; que comprende la transposicion oxidativa de un compuesto de formula (II) o un solvato del mismo. Tambien se refiere a compuestos intermedios de los mismos, y procedimiento para la preparacion de bilastina.
PE2021000095A 2018-07-24 2019-07-23 Procedimiento y productos intermedios para la preparacion de bilastina PE20211243A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382556.1A EP3599235A1 (en) 2018-07-24 2018-07-24 Process and intermediates for the preparation of bilastine
PCT/EP2019/069772 WO2020020873A1 (en) 2018-07-24 2019-07-23 Process and intermediates for the preparation of bilastine

Publications (1)

Publication Number Publication Date
PE20211243A1 true PE20211243A1 (es) 2021-07-13

Family

ID=63103892

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2021000095A PE20211243A1 (es) 2018-07-24 2019-07-23 Procedimiento y productos intermedios para la preparacion de bilastina

Country Status (27)

Country Link
US (1) US11370742B2 (es)
EP (2) EP3599235A1 (es)
JP (1) JP7145312B2 (es)
KR (1) KR20210038905A (es)
CN (1) CN112469709A (es)
AU (1) AU2019311251B2 (es)
BR (1) BR112021001179A2 (es)
CA (1) CA3107879A1 (es)
CL (1) CL2021000171A1 (es)
CO (1) CO2021000940A2 (es)
CY (1) CY1124909T1 (es)
EA (1) EA202190346A1 (es)
EC (1) ECSP21008461A (es)
ES (1) ES2901786T3 (es)
HR (1) HRP20211994T1 (es)
HU (1) HUE056822T2 (es)
LT (1) LT3826997T (es)
MA (1) MA53370B1 (es)
MX (1) MX2021000924A (es)
PE (1) PE20211243A1 (es)
PH (1) PH12021550144A1 (es)
PL (1) PL3826997T3 (es)
PT (1) PT3826997T (es)
SG (1) SG11202100576WA (es)
SI (1) SI3826997T1 (es)
WO (1) WO2020020873A1 (es)
ZA (1) ZA202101214B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
WO2022214921A1 (en) * 2021-04-10 2022-10-13 Ocimum Labs Private Limited An improved process for the preparation of intermediates used in the preparation of antihistamine agent
WO2023037184A2 (en) * 2021-08-19 2023-03-16 Biophore India Pharmaceuticals Pvt. Ltd Novel process for the preparation of bilastine and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108943A (en) * 1976-03-10 1977-09-12 Teikoku Hormone Mfg Co Ltd Alkyl phenyl ketone derivative
WO2009050116A2 (en) * 2007-10-17 2009-04-23 Basf Se Adhesion promoting photoinitiators for uv cured coatings over metal surfaces
EP2240464A4 (en) 2008-02-12 2011-09-14 Yuhan Corp PROCESS FOR THE PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS
CN102675101B (zh) 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CN103159674A (zh) 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
CN104151160A (zh) 2013-05-15 2014-11-19 重庆华邦制药有限公司 用酯类化合物合成2-甲基丙酸酯衍生物的方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN104326909A (zh) 2014-09-22 2015-02-04 暨南大学 一种制备α,α-二甲基-4-(2-卤乙基)苯乙酸酯及合成比拉斯汀的方法

Also Published As

Publication number Publication date
HRP20211994T1 (hr) 2022-04-01
MA53370B1 (fr) 2021-12-31
WO2020020873A1 (en) 2020-01-30
CA3107879A1 (en) 2020-01-30
ECSP21008461A (es) 2021-03-31
MA53370A (fr) 2021-06-02
JP2021531300A (ja) 2021-11-18
EP3599235A1 (en) 2020-01-29
PT3826997T (pt) 2022-01-21
PL3826997T3 (pl) 2022-05-30
ZA202101214B (en) 2022-09-28
CO2021000940A2 (es) 2021-02-17
EP3826997B1 (en) 2021-11-10
US20210300856A1 (en) 2021-09-30
US11370742B2 (en) 2022-06-28
SI3826997T1 (sl) 2022-01-31
PH12021550144A1 (en) 2021-09-13
ES2901786T3 (es) 2022-03-23
BR112021001179A2 (pt) 2021-04-27
AU2019311251A1 (en) 2021-03-04
AU2019311251B2 (en) 2021-10-21
CY1124909T1 (el) 2023-01-05
HUE056822T2 (hu) 2022-03-28
CL2021000171A1 (es) 2021-07-09
LT3826997T (lt) 2021-12-27
SG11202100576WA (en) 2021-02-25
CN112469709A (zh) 2021-03-09
JP7145312B2 (ja) 2022-09-30
MX2021000924A (es) 2021-03-31
EA202190346A1 (ru) 2021-05-20
KR20210038905A (ko) 2021-04-08
EP3826997A1 (en) 2021-06-02

Similar Documents

Publication Publication Date Title
AR114631A1 (es) Métodos e intermedios para preparar compuestos de piridina
CL2019003154A1 (es) Proceso de preparación de un compuesto intermediario de fórmula (vi) para la preparación de compuestos de cannabidiol. (divisional solicitud 201800079)
UY38076A (es) Derivados de tetrahidroquinazolina útiles como agentes anticáncer
PE20211243A1 (es) Procedimiento y productos intermedios para la preparacion de bilastina
CL2018000952A1 (es) Compuestos útiles como inmunomoduladores
DOP2018000268A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
AR111304A1 (es) Métodos para sintetizar un inhibidor de mcl-1
CR20190504A (es) COMPUESTO DE AMIDA (Divisional 2015-0454)
AR102468A1 (es) Métodos para la preparación de ribósidos
AR106141A1 (es) Métodos e intermediarios para la preparación de derivados de ácidos biliares
PE20180327A1 (es) Proceso para preparar 4-amino-piridazinas
CL2018001210A1 (es) Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico.
CY1124450T1 (el) Νουκλεοτιδια βητα-νικοτινικου εστερα και διεργασιες για την παρασκευη αυτων
EA201992421A1 (ru) Способ получения озанимода
CL2019002297A1 (es) Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos.
BR112018073490A2 (pt) 6.7.beta-epóxidos esteroides como intermediários químicos
AR104488A1 (es) Alcoxilatos de alcohol de intervalo estrecho y derivados de estos
BR112018074287A2 (pt) processo para preparação de eribulina e intermediários da mesma
AR109328A1 (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana
CU20200047A7 (es) Compuestos de alquinileno sustituidos como agentes anticancerígenos
AR093168A1 (es) COMPUESTOS DE OXAZOLIDINONA COMO INHIBIDORES DEL CANAL KCa3.1
ES2670477R1 (es) Procedimiento para la preparacion de la 17beta-hidroxi-des-a-androst-9,10-en-5-ona
AR102569A1 (es) Síntesis de inhibidor de pi3k, formas cristalinas y sales del mismo y una composición farmacéutica que lo comprende
AR116973A1 (es) Compuestos de organoazufre
MX2021006692A (es) Proceso mejorado para preparar ozanimod.